Filtros de búsqueda

Lista de obras de John Mascarenhas

1090. Practicing Antimicrobial Stewardship: De-escalating Empiric Antibiotics in Patients with Acute Myelogenous Leukemia and Neutropenic Fever

A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature ⬇️

artículo científico publicado el 15 de noviembre de 2012

A comprehensive review and analysis of the effect of ruxolitinib therapy on the survival of patients with myelofibrosis ⬇️

artículo científico publicado el 9 de abril de 2013

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).

artículo científico publicado en 2013

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF)

artículo científico publicado en 2019

A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

artículo científico publicado en 2014

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

scientific article published on 30 July 2019

A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells

artículo científico publicado en 2016

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

artículo científico publicado en 2020

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

scientific article published on 01 December 2018

Advances in myelofibrosis: a clinical case approach ⬇️

artículo científico publicado el 1 de octubre de 2013

An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

artículo científico publicado en 2020

Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera

artículo científico

Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms ⬇️

artículo científico publicado en 2018

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies

artículo científico publicado en 2016

Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery

artículo científico publicado en 2020

Clarifying the use of ruxolitinib in patients with myelofibrosis

artículo científico publicado el 1 de julio de 2013

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms

scientific article published on 11 March 2020

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia

artículo científico publicado en 2020

Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia.

artículo científico publicado en 2013

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells

artículo científico publicado en 2012

Comment on "Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis"

artículo científico publicado en 2020

Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia

artículo científico publicado en 2019

Continued Role of Splenectomy in the Management of Patients With Myelofibrosis

artículo científico publicado en 2016

Current and evolving understanding of atypical chronic myeloid leukemia

scientific article published on 29 July 2018

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

artículo científico publicado en 2020

Development of extramedullary sites of leukaemia during ruxolitinib therapy for myelofibrosis

artículo científico publicado en 2014

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression

artículo científico publicado en 2011

Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients

artículo científico publicado en 2018

Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey

artículo científico publicado en 2016

Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.

artículo científico publicado en 2016

Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I.

artículo científico publicado en 2014

Eosinophilia in acute myeloid leukemia: Overlooked and underexamined

scientific article published on 30 March 2019

Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies ⬇️

artículo científico publicado el 9 de julio de 2011

Evolving Understanding of Chronic Myelomonocytic Leukemia: Implications for Future Treatment Paradigms

artículo científico publicado en 2018

Experience with pegylated interferon -2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients ⬇️

artículo científico publicado el 14 de marzo de 2012

Hemichorea in a patient with JAK2V617F blood cells ⬇️

artículo científico publicado el 14 de febrero de 2013

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study

artículo científico publicado en 2020

Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia

artículo científico publicado en 2018

Increased differentiation of dermal mast cells in mice lacking the Mpl gene

artículo científico publicado en 2009

Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway

artículo científico publicado en 2010

Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes

artículo científico publicado en 2016

Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations

article

MDM2 inhibition: an important step forward in cancer therapy

scientific article published on 10 July 2020

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

artículo científico publicado en 2014

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

artículo científico publicado en 2013

Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms

scientific article published on 12 November 2019

Modern management of splenomegaly in patients with myelofibrosis

artículo científico publicado en 2020

Myeloid/lymphoid neoplasms with FGFR1 rearrangement

artículo científico publicado en 2017

Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey

artículo científico publicado en 2016

Myeloproliferative neoplasms: new translational therapies

artículo científico publicado en 2010

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review

artículo científico publicado en 2019

Novel Therapies in Polycythemia Vera

artículo científico publicado en 2020

Novel therapeutics in myeloproliferative neoplasms

scientific article published on 02 December 2020

Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials

artículo científico publicado en 2014

Oral idasanutlin in patients with polycythemia vera

scientific article published on 05 June 2019

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis

artículo científico publicado en 2016

Outcomes and predictors of survival in blast phase myeloproliferative neoplasms

artículo científico publicado en 2018

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.

artículo científico publicado en 2015

Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study.

artículo científico publicado en 2018

Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience

scientific article published on 16 October 2019

Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden

artículo científico publicado en 2020

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial

artículo científico publicado en 2018

Panobinostat (LBH589)-induced acetylation of tubulin impairs megakaryocyte maturation and platelet formation ⬇️

artículo científico publicado el 27 de febrero de 2012

Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm

artículo científico publicado en 2014

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

artículo científico publicado en 2019

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

scientific article published on 27 February 2020

Pharmacotherapy of Myelofibrosis

artículo científico publicado en 2017

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

artículo científico publicado en 2020

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

scientific article published on 22 January 2019

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

artículo científico publicado en 2015

Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation

artículo científico publicado en 2020

Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever

scientific article published on 21 April 2020

Preferences of Patients With Myeloproliferative Neoplasms for Accepting Anxiety or Depression Treatment

artículo científico publicado en 2016

Prevalence of Cytopenia in the General Population-A National Health and Nutrition Examination Survey Analysis

artículo científico publicado en 2020

Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders

artículo científico publicado en 2017

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis

artículo científico publicado en 2016

Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms

artículo científico publicado en 2017

Psychological Manifestations of Early Childhood Adversity in the Context of Chronic Hematologic Malignancy

artículo científico publicado en 2016

Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms

artículo científico publicado en 2016

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

artículo científico publicado en 2020

Reassessing the Safety Concerns of Utilizing Blood Donations from Patients with Hemochromatosis.

artículo científico publicado en 2017

Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis

scientific article published on 11 February 2020

Refractory gout in primary myelofibrosis

artículo científico publicado en 2019

Relevant updates in systemic mastocytosis

scientific article published on 04 April 2019

Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera

artículo científico publicado en 2019

Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis

artículo científico publicado en 2019

Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.

artículo científico publicado en 2018

SLAM dunk for myelofibrosis?

scientific article published on 01 September 2019

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis

artículo científico publicado en 2020

Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis

artículo científico publicado en 2015

Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial

artículo científico publicado en 2013

Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition

artículo científico publicado en 2022

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement

artículo científico publicado en 2024

Systemic Mastocytosis: Clinical Update and Future Directions.

artículo científico

The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib

article

The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease

artículo científico publicado en 2020

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

artículo científico publicado en 2020

The future of JAK inhibition in myelofibrosis and beyond

artículo científico

The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome

artículo científico publicado en 2009

The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes

scientific article published on 01 February 2020

The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis

artículo científico publicado en 2020

Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin

artículo científico publicado en 2020

Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells

artículo científico publicado en 2010

Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm

scientific article published on 22 September 2020

Why Does My Patient Have Erythrocytosis? ⬇️

artículo científico publicado el 1 de abril de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda